» Articles » PMID: 35242558

Helicobacter Pylori Infection Manifesting As Hypereosinophilic Syndrome and Immune Thrombocytopenia Complicated by Portal Vein Thrombosis and Ischemic Colitis

Overview
Journal IDCases
Date 2022 Mar 4
PMID 35242558
Authors
Affiliations
Soon will be listed here.
Abstract

Hypereosinophilic syndromes (HES) are a group of uncommon disorders characterized by persistent eosinophils overproduction which can lead to tissue damage and organs dysfunction secondary to eosinophils tissue infiltration and inflammatory mediators' release. Causes of secondary HES include parasitic infection, some solid tumors, underlying connective tissue disease, allergic conditions and T cell lymphoma. has been reported only once as a cause of secondary HES in the literature. We report the second case of infection in 29-year-old male patient who presents with HES and secondary Immune thrombocytopenic purpura (ITP). This case is different from the first reported case by the presence of HES complication on presentation manifesting as portal vein thrombosis, which was further complicated by ischemic colitis. eradication therapy alone was successful in a resolution of hypereosinophilia and platelets recovery without the need of corticosteroids or any other treatment.

Citing Articles

Idiopathic hypereosinophilic syndrome with hepatic sinusoidal obstruction syndrome: A case report and literature review.

Xu X, Wang B, Wang Q, Guo Y, Zhang Y, Chen X World J Gastrointest Surg. 2023; 15(7):1532-1541.

PMID: 37555104 PMC: 10405125. DOI: 10.4240/wjgs.v15.i7.1532.

References
1.
Kuwana M . Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J Gastroenterol. 2014; 20(3):714-23. PMC: 3921481. DOI: 10.3748/wjg.v20.i3.714. View

2.
Stasi R, Sarpatwari A, Segal J, Osborn J, Evangelista M, Cooper N . Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2008; 113(6):1231-40. DOI: 10.1182/blood-2008-07-167155. View

3.
Liu Y, Meng X, Feng J, Zhou X, Zhu H . Hypereosinophilia with Concurrent Venous Thromboembolism: Clinical Features, Potential Risk Factors, and Short-term Outcomes in a Chinese Cohort. Sci Rep. 2020; 10(1):8359. PMC: 7239859. DOI: 10.1038/s41598-020-65128-4. View

4.
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold D . Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2008; 113(11):2386-93. DOI: 10.1182/blood-2008-07-162503. View

5.
Mohamed M, Al-Shokri S, Shunnar K, Mohamed S, Najim M, Ibrahim S . Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2021; 7:598846. PMC: 7874113. DOI: 10.3389/fcvm.2020.598846. View